Boom-IBD Clinical Trial
NCT05414955 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40
Last updated 2025-06-29
Summary
Feasibility study of neuromodulation in patients with IBD.
Conditions
Interventions
- DEVICE
-
Neuromodulation
Neuromodulation
Sponsors & Collaborators
-
Boomerang Medical
lead INDUSTRY
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-10-01
- Primary Completion
- 2024-12-06
- Completion
- 2024-12-06
- FDA Device
- Yes
Countries
- United States
Study Locations
More Related Trials
-
Microbial and Human Determinants of the Onset of IBD Flares
NCT05463900 ·Status: ACTIVE_NOT_RECRUITING
-
Evaluation of the SMART IBD App in Pediatric IBD
NCT07195123 ·Status: RECRUITING ·Phase: NA
-
Combination Therapy With Two Biologicals
NCT05135221 ·Status: COMPLETED
-
LFMT vs Placebo in New Biologic Start for Ulcerative Colitis
NCT05327790 ·Status: RECRUITING ·Phase: PHASE2
-
The Inflammatory Bowel Disease - Anti-Inflammatory Diet (IBD-AID)
NCT04757181 ·Status: COMPLETED ·Phase: NA
-
Mechanism of Chronic Pain in Patients With IBD
NCT04995224 ·Status: RECRUITING
-
Interactions Between Immune Cells of Intestinal Mucosa or Peripheral Blood With the Extracellular Matrix in Inflammatory Bowel Disease (IBD)
NCT00915044 ·Status: UNKNOWN
-
Advanced Therapy Registry of IBD Patients
NCT04998084 ·Status: UNKNOWN
-
Open-Label Adalimumab for Ulcerative Colitis Patients
NCT00421642 ·Status: COMPLETED ·Phase: PHASE1
-
De-escalation of Anti-TNF Therapy in Inflammatory Bowel Disease
NCT04646187 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE4
-
Budesonide for Induction of Remission in Incomplete Microscopic Colitis
NCT02142634 ·Status: COMPLETED ·Phase: PHASE3
-
Mobile Application for IBD Patients With Biologics
NCT04254614 ·Status: COMPLETED ·Phase: NA
-
A Comprehensive Self-Management Intervention for Individuals With Inflammatory Bowel Disease
NCT05651542 ·Status: COMPLETED ·Phase: NA
-
Determination of the Optimal Treatment Target in Ulcerative Colitis
NCT04259138 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4
-
A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease
NCT07113522 ·Status: RECRUITING ·Phase: PHASE2
-
A Prospective Study on the Incidence and Risk Factors Related to Infection in Patients With Inflammatory Bowel Disease
NCT02904590 ·Status: COMPLETED
-
Observational, Real World Study Of Inflectra In Patients With Inflammatory Bowel Disease
NCT03801928 ·Status: COMPLETED
-
A Study of the Human Anti-TNF Antibody Adalimumab for the Induction of Clinical Remission in Subjects With Crohn's Disease
NCT00055523 ·Status: COMPLETED ·Phase: PHASE2
-
SMART-IBD App Trial
NCT06023667 ·Status: COMPLETED ·Phase: NA
-
Immune Regulation in Ulcerative Colitis or Crohn s Disease
NCT00001184 ·Status: RECRUITING
-
Therapeutic Drug Monitoring for Biological Therapy in Pediatric Inflammatory Bowel Disease
NCT06954311 ·Status: RECRUITING
-
(CB-01-02/04) Extension Study of Budesonide Multi-Matrix System (MMX) 6 mg in Maintenance Of Remission In Patients With Ulcerative Colitis.
NCT00801723 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluation of Molecular Mechanisms of Non-response to Therapy in Patients With Inflammatory Bowel Disease
NCT05733845 ·Status: RECRUITING ·Phase: NA
-
Fecal Microbiota Transplantation (FMT) in the Management of Active Ulcerative Colitis
NCT02227342 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
The Home Telemanagement (UC HAT) Trial for Patients With Ulcerative Colitis
NCT00620126 ·Status: COMPLETED ·Phase: PHASE3